)
Visual
test
Masimo
Masimo (MASI) investor relations material
Masimo 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Business performance and financial highlights
Achieved over $1.5 billion in revenue, 9%+ annual growth, and 11%+ quarterly growth in Q4, with 500 basis points margin expansion and 30%+ EPS growth in the past year.
80%+ recurring revenue and 99%+ renewal rate, with a resilient supply chain and strong engineering retention.
Guidance met or exceeded for revenue and earnings, expecting to close the year at the high end of guidance.
Long-range plan targets 7%-10% annual growth and 30% operating margin by 2028, with EPS approaching $8.
Strong cash flow and share buybacks, with natural leverage expected to drive future profitability.
Strategic focus and growth drivers
Growth strategy centers on U.S. pulse oximetry (40% of growth), international expansion (20%), advanced monitoring (one-third), and new product launches.
U.S. pulse ox market share at 55%, growing 1-2 points per year; international share at 35% in a faster-growing $800M market.
Advanced monitoring market share at 10%-15%, with double-digit growth potential.
Continuous monitoring seen as a $2B market opportunity, pending regulatory and technological advances.
Focused on commercial excellence, innovation, and expanding in Japan and Asia-Pacific, where significant growth potential exists.
Innovation, product pipeline, and AI integration
New product launches planned in every major category, including next-gen monitors and wearables.
AI and algorithm development are core strengths, with a dedicated team and a pipeline including AFib detection, opioid-induced respiratory depression, and predictive analytics.
Radius VSM, a wearable vital signs monitor, moving from pilot to full launch; next-gen Root monitors to launch by end of 2027.
Smart sensors for opioid-induced respiratory depression and AFib detection submitted to FDA, with launches expected in 2026.
Wearable strategy being developed for continuous hospital monitoring, with multiple FDA-cleared devices already in portfolio.
Multicenter study for continuous monitoring impact
Japan/APAC growth strategy and expected impact?
Next-gen monitor refresh cycle revenue potential?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebGICRE
Net profit for the nine months surged to ₹6,62,217 lakhs, with a robust solvency ratio of 3.87. - 7 Feb517271
Strong revenue and profit growth, interim dividend, and major investments approved. - 7 Feb514167
Quarterly and nine-month results reflect solid revenue, profit, and compliance with new labour codes. - 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus.
Next Masimo earnings date
Q4 202526 Feb, 2026
Masimo
Next Masimo earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Masimo Corporation is a medical technology company that develops noninvasive monitoring technologies and devices. The company’s product portfolio includes pulse oximetry, brain function monitoring, and hospital automation solutions. It serves hospitals, medical professionals, and consumers globally. Masimo Corporation is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage